SA
MED icon

Scarborough Advisors’s Medifast MED Stock Holding History

Scarborough Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$82 – 455
2026
Q1 		$82 Hold
8
– – ﹤0.01% 738
2025
Q4 		$85 Hold
8
– – ﹤0.01% 446
2025
Q3 		$109 Hold
8
– – ﹤0.01% 452
2025
Q2 		$112 Buy
+8
New +$105 ﹤0.01% 442
2024
Q3 		– Sell
-97
Closed -$2.11K – 307
2024
Q2 		$2.11K Hold
97
– – ﹤0.01% 307
2024
Q1 		$3.7K Hold
97
– – ﹤0.01% 276
2023
Q4 		$6.5K Buy
+97
New +$6.76K ﹤0.01% 440

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Scarborough Advisors's MED Position: Q2 2026 in Review

Scarborough Advisors sold out of Medifast (MED) in Q2 2026, closing a stake of 8 shares — an estimated $82 sold.

Scarborough Advisors first reported a position in MED in Q4 2023 and held it in 7 quarters. The position peaked at $6.5K in Q4 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Scarborough Advisors reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 8 Medifast shares in Q2 2026, an estimated $82.
  • Scarborough Advisors first reported a position in Medifast in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's Medifast position peaked at $6.5K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.